Trump unveils plan for cutting drug prices. Will it work?

May 11, 2018
President Donald Trump on Friday took the wraps off his long-awaited plan for cutting drug prices. In a speech, the president announced measures to increase competition and pricing transparency as ways to drive down costs, which have been spiraling. He did not put forward any plan to use the huge buying power of the federal […]

3 things to look for in Trump’s speech on drug pricing

May 10, 2018
The president is set to talk about his plans to lower the price of drugs on Friday.
Joe Raedle/Getty Images

This cancer patient is devoting his life to making drugs more affordable

May 17, 2017
David Mitchell's advocacy group aims to bring down prescription prices by harnessing the power of patient stories.
Advocate David Mitchell says drugs are so expensive that some people are losing their homes or using college savings. Above, chemotherapy drugs.
Chris Hondros/Getty Images

Why health care is like a Rubik's Cube

Apr 12, 2017
Dr. Elisabeth Rosenthal talks about her new book and the danger of all-or-nothing politics.
PATRIK STOLLARZ/AFP/Getty Images

Trump tells big pharma to cut their 'astronomical' drug prices

Feb 1, 2017
Will drug companies agree to the president's proposal?
 President Donald Trump meets with representatives from PhRMA, the Pharmaceutical Research and Manufacturers of America, on Tuesday.
Ron Sachs - Pool/Getty Images

Clinton drug plan: is it enough?

Sep 2, 2016
What would it take to control drug prices?
Rather than tackling the soaring prices of drugs overall, Clinton economic policy advisor Mike Shapiro said their plan is to address the insidious problem where a subset of drug makers crank up prices on generics, just because they can.
FRANCK FIFE/AFP/Getty Images

Drug prices still escalating and not stopping any time soon

Jul 14, 2016
Drug price inflation soars even as prices in the wider economy are stable.
Americans continue to spend on drugs at an increasing rate. 
Tim Boyle/Getty Images

The future is bright… let’s make it even brighter together.

Be a Marketplace Investor with a donation in any amount today.

New class of generics could save consumers, insurers billions. FDA is moving carefully.

Jul 13, 2016
The European Union has some 20 "biosimilar" generics on the market; the US has one.
Pre-filled syringes of  the adalimumab biosimilar.  The biosimilar is used in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis and ankylosing spondylitis.
SAM PANTHAKY/AFP/Getty Images

Turns out hedge funds have an incentive to control drug prices

Apr 25, 2016
Hedge funds are joining groups who want to lower prescription prices for consumers.
Big Pharma doesn't like the patent review board. But organizations that want to lower prescription prices for consumers love it, and they're being joined in their fight by people who aren't usually seen as champions of consumer rights — hedge fund managers.
Photo by Joe Raedle/Getty Images

Valeant's story: a cautionary tale

Mar 21, 2016
The company's CEO stepped down on Monday
Howard Schiller, then interim CEO of Valeant Pharmaceuticals International, Inc., listens during a hearing of the House Oversight and Government Reform Committee on Capitol Hill February 4, 2016 in Washington, DC. 
BRENDAN SMIALOWSKI/AFP/Getty Images